Clinical Trial Update: Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sorafenib in combination with FOLFOX6 or FOLFIRI as second-line treatment for colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Colorectal Neoplasms | Phase 2 | Status: TERMINATED